Anupam Rama
Stock Analyst at J.P. Morgan
(4.89)
# 286
Out of 4,456 analysts
774
Total ratings
54.3%
Success rate
24.2%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REPL Replimune Group | Upgraded: Buy | $8 → $17 | $11.63 | +46.17% | 32 | Jun 26, 2026 | |
| CAMP Camp4 Therapeutics | Upgraded: Buy | $9 | $4.20 | +114.29% | 3 | Jun 22, 2026 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | n/a | $11.39 | - | 28 | Jun 9, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $124 | $123.52 | +0.39% | 23 | Jun 9, 2026 | |
| FULC Fulcrum Therapeutics | Downgraded: Sell | n/a | $3.80 | - | 5 | Jun 2, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | n/a | $38.10 | - | 16 | May 31, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $54 → $53 | $58.85 | -9.94% | 19 | May 29, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $81 → $66 | $36.74 | +79.64% | 37 | May 29, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $74 → $72 | $30.77 | +133.99% | 28 | May 22, 2026 | |
| ANAB AnaptysBio | Maintained: Buy | $69 → $70 | $63.15 | +10.85% | 34 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $18.00 | +50.00% | 21 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $9.29 | +18.41% | 16 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $86 | $42.46 | +102.54% | 32 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $53 | $28.43 | +86.42% | 11 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $16.03 | +87.15% | 2 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $19 | $16.85 | +12.76% | 63 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $56 | $35.94 | +55.82% | 21 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $16.01 | +43.66% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $100 | $70.24 | +42.37% | 42 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $185 | $168.52 | +9.78% | 64 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $59.20 | +21.62% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.53 | - | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.83 | - | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.32 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.48 | - | 20 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $3.40 | +252.94% | 12 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $45 | $21.31 | +111.17% | 24 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $14.00 | +35.71% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $13.73 | +133.07% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $16.10 | +148.45% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $8.88 | -32.43% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.00 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $204 → $170 | $291.37 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.32 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $5 | $10.39 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $64 | $82.19 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $26 | $3.68 | n/a | 6 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $48 | $37.90 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $87.89 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $45 | $121.88 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.70 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $17.63 | n/a | 7 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $54.76 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $10.03 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.000001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $12.70 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $20.94 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.92 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $38.69 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $8 | $0.195 | n/a | 4 | Nov 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $84.43 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $115.72 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $4.13 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.19 | n/a | 4 | Jun 15, 2016 |
Replimune Group
Jun 26, 2026
Upgraded: Buy
Price Target: $8 → $17
Current: $11.63
Upside: +46.17%
Camp4 Therapeutics
Jun 22, 2026
Upgraded: Buy
Price Target: $9
Current: $4.20
Upside: +114.29%
Olema Pharmaceuticals
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $11.39
Upside: -
Nuvalent
Jun 9, 2026
Downgraded: Hold
Price Target: $124
Current: $123.52
Upside: +0.39%
Fulcrum Therapeutics
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.80
Upside: -
Cogent Biosciences
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $38.10
Upside: -
Travere Therapeutics
May 29, 2026
Maintained: Buy
Price Target: $54 → $53
Current: $58.85
Upside: -9.94%
IDEAYA Biosciences
May 29, 2026
Maintained: Buy
Price Target: $81 → $66
Current: $36.74
Upside: +79.64%
Ultragenyx Pharmaceutical
May 22, 2026
Maintained: Buy
Price Target: $74 → $72
Current: $30.77
Upside: +133.99%
AnaptysBio
May 22, 2026
Maintained: Buy
Price Target: $69 → $70
Current: $63.15
Upside: +10.85%
May 22, 2026
Maintained: Buy
Price Target: $27
Current: $18.00
Upside: +50.00%
May 22, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $9.29
Upside: +18.41%
May 22, 2026
Maintained: Buy
Price Target: $90 → $86
Current: $42.46
Upside: +102.54%
May 22, 2026
Maintained: Buy
Price Target: $58 → $53
Current: $28.43
Upside: +86.42%
May 22, 2026
Maintained: Buy
Price Target: $31 → $30
Current: $16.03
Upside: +87.15%
May 18, 2026
Maintained: Hold
Price Target: $18 → $19
Current: $16.85
Upside: +12.76%
May 13, 2026
Maintained: Buy
Price Target: $60 → $56
Current: $35.94
Upside: +55.82%
May 13, 2026
Maintained: Buy
Price Target: $23
Current: $16.01
Upside: +43.66%
May 12, 2026
Maintained: Buy
Price Target: $94 → $100
Current: $70.24
Upside: +42.37%
May 8, 2026
Rated: Buy
Price Target: $177 → $185
Current: $168.52
Upside: +9.78%
May 4, 2026
Maintained: Buy
Price Target: $68 → $72
Current: $59.20
Upside: +21.62%
Apr 13, 2026
Maintained: Buy
Price Target: n/a
Current: $9.53
Upside: -
Mar 25, 2026
Maintained: Hold
Price Target: n/a
Current: $1.83
Upside: -
Mar 24, 2026
Maintained: Sell
Price Target: n/a
Current: $1.32
Upside: -
Mar 18, 2026
Maintained: Buy
Price Target: n/a
Current: $5.48
Upside: -
Mar 16, 2026
Upgraded: Buy
Price Target: $7 → $12
Current: $3.40
Upside: +252.94%
Mar 9, 2026
Maintained: Buy
Price Target: $33 → $45
Current: $21.31
Upside: +111.17%
Mar 3, 2026
Maintained: Buy
Price Target: $19
Current: $14.00
Upside: +35.71%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.73
Upside: +133.07%
Dec 18, 2025
Maintained: Buy
Price Target: $40
Current: $16.10
Upside: +148.45%
Nov 18, 2025
Maintained: Sell
Price Target: $6
Current: $8.88
Upside: -32.43%
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $16.00
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $204 → $170
Current: $291.37
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.32
Upside: n/a
Aug 15, 2022
Maintained: Hold
Price Target: $27 → $5
Current: $10.39
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $55 → $64
Current: $82.19
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $31 → $26
Current: $3.68
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $50 → $48
Current: $37.90
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $9 → $8
Current: $87.89
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $51 → $45
Current: $121.88
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.70
Upside: n/a
Feb 25, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $17.63
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $55
Current: $54.76
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $10.03
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $12.70
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $20.94
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $1.92
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $7 → $6
Current: $38.69
Upside: n/a
Nov 5, 2018
Downgraded: Sell
Price Target: $18 → $8
Current: $0.195
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $84.43
Upside: n/a
Sep 29, 2017
Maintained: Hold
Price Target: n/a
Current: $115.72
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $4.13
Upside: n/a
Jun 15, 2016
Maintained: Hold
Price Target: n/a
Current: $13.19
Upside: n/a